Please login to the form below

Not currently logged in
Email:
Password:

Dr Olivier Danos joins TxCell scientific advisory board

He currently serves as cell and gene therapy SVP at Biogen

TxCell Dr Olivier DanosFrench biotechnology company TxCell has appointed Biogen's Dr Olivier Danos to its scientific advisory board.

Since 2014, Dr Danos has served as senior vice president of cell and gene therapy at Biogen, leading its research group to develop new technologies for gene transfer and genome engineering.

Before to taking up this role in 2011, Dr Danos was Kadmon Pharmaceutical's senior vice president for molecular science, synthetic biology and gene regulation, where he led the creation of its gene therapy and technology platforms.

He has also served as director of the Gene Therapy Consortium at University College London, scientific director of Généthon, and senior research director for France's National Centre for Scientific Research (CNRS).

Arnoud Foussat, chief scientific officer at TxCell, said: “Dr Olivier Danos has pioneered technologies of central importance in the field of gene therapy and genome editing.

“He is another significant addition to our scientific advisory board, which already includes leading experts in immunology, T-cell biology and chimeric antigen receptors.

“We are looking forward to their insights and advice on our current and future research and development programmes targeting severe chronic autoimmune and inflammatory diseases.”

1st September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics